Schlossberg minced no words about the damage she believes Kennedy’s actions have and will inflict on cancer patients and on medical research.
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...
Doctors say her struggle - even with the best care as a member of a prominent family - emphasises the need for more research.
Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the ...
Clinical validation successfully completed with Mayo Clinic Platform’s Validate program - marking the final clinical requirement prior to FDA 510(k) submission EchoSolv HF validation met the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results